| Patent | Date |
|---|
OB-fold used as scaffold for engineering new specific binders
Grant 11,434,585 - Pecorari , et al. September 6, 2 | 2022-09-06 |
Ob-fold Used As Scaffold For Engineering New Specific Binders
App 20200181601 - Pecorari; Frederic ; et al. | 2020-06-11 |
OB-fold used as scaffold for engineering new specific binders
Grant 10,584,330 - Pecorari , et al. | 2020-03-10 |
Ob-fold Used As Scaffold For Engineering New Specific Binders
App 20170166887 - Pecorari; Frederic ; et al. | 2017-06-15 |
OB-fold used as scaffold for engineering new specific binders
Grant 9,422,548 - Pecorari , et al. August 23, 2 | 2016-08-23 |
OB-Fold Used As Scaffold For Engineering New Specific Binders
App 20160010083 - Pecorari; Frederic ; et al. | 2016-01-14 |
Crystallographic structure of TcPRACA and uses therefor
App 20130143201 - Minoprio; Paola ; et al. | 2013-06-06 |
Crystallographic structure of Trypanosoma cruzi proline racemase and uses therefor
Grant 8,099,245 - Minoprio , et al. January 17, 2 | 2012-01-17 |
Peptides Of Il-2
App 20100273723 - Theze; Jacques ; et al. | 2010-10-28 |
Active Or Passive Immunization Against Proapoptotic Neurotrophins For The Treatment And/or Prevention Of Neurodegenerative Diseases
App 20100183645 - Barbeito; Luis Hector ; et al. | 2010-07-22 |
Ob-fold Used As Scaffold For Engineering New Specific Binders
App 20100145008 - Pecorari; Frederic ; et al. | 2010-06-10 |
Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2
Grant 7,704,490 - Theze , et al. April 27, 2 | 2010-04-27 |
Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2
Grant 7,662,368 - Theze , et al. February 16, 2 | 2010-02-16 |
Crystallographic structure of TcPRACA and uses therefor
Grant 7,585,656 - Minoprio , et al. September 8, 2 | 2009-09-08 |
Crystallographic Structure Of Tcpraca And Uses Therefor
App 20080113422 - Minoprio; Paola ; et al. | 2008-05-15 |
PknB kinase and pstP phosphatase and methods of identifying inhibitory substances
Grant 7,364,856 - Alzari , et al. April 29, 2 | 2008-04-29 |
Pknb kinase and pstp phosphatase and methods of identifying inhibitory substances
App 20070128678 - Alzari; Pedro ; et al. | 2007-06-07 |
Peptides of IL-2
App 20070048302 - Theze; Jacques ; et al. | 2007-03-01 |
Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases
App 20060275290 - Barbeito; Luis Hector ; et al. | 2006-12-07 |
Peptides of IL-2
Grant 7,101,965 - Theze , et al. September 5, 2 | 2006-09-05 |
PknB kinase and pstP phosphatase and methods of identifying inhibitory substances
App 20060019324 - Alzari; Pedro ; et al. | 2006-01-26 |
Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
App 20060018873 - Theze; Jacques ; et al. | 2006-01-26 |
Crystallographic structure of TcPRACA and uses therefor
App 20050250195 - Minoprio, Paola ; et al. | 2005-11-10 |
Peptides of IL-2 and derivatives thereof
Grant 6,929,791 - Theze , et al. August 16, 2 | 2005-08-16 |
Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
Grant 6,825,334 - Theze , et al. November 30, 2 | 2004-11-30 |
Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
App 20040202661 - Theze, Jacques ; et al. | 2004-10-14 |
Crystal structure of the mouse apoptosis-inducing factor AIF and applications of such structural data to structure-based identification, screening, or design of AIF agonists or antagonists as well as AIF fragments, mutants or variants
App 20040106119 - Alzari, Pedro | 2004-06-03 |
Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
App 20020044935 - Theze, Jacques ; et al. | 2002-04-18 |
| 